MIR7158

Across TCGA pan-cancer cohorts, MIR7158 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR7158’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR7158 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR7158 is over-expressed in tumor, although a few such as LUSC and ESCA show the opposite, repressed pattern.

BRCA, LUSC, and ESCA are the cancer types where MIR7158 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR7158 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.110	.006	4	view →
LUSC	All	All	−0.138	.012	3	view →
ESCA	All	All	−0.983	.030	1	view →
LUAD	Female	All	−0.207	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR7158–BRCA

Open the BRCA breakdown →